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Background and Objectives
Dried blood spots (DBS) are routinely
collected within 24–48 hr of birth from
> 98% of all newborns babies in the United
States. DBS are collected using a heel stick
with spotting of the blood onto the Guthrie
card (Guthrie 1969). The DBS are screened
by state public health laboratories or their
associated laboratories for inborn errors of
metabolism and other disorders. Appropriate
collection procedures include completely fill-
ing the preprinted circles with blood so that
the blood soaks through to the back of the
paper; drying the blood thoroughly before
storage or transportation; packing the DBS
with desiccant and in low-gas–permeable
bags; and keeping the spots at –20°C for long-
term storage (Hannon et al. 2003). Because
measurements on DBS can be quantitative,
appropriate collection and storage are impor-
tant for maintaining the integrity of speci-
mens and for minimizing the variation in
whole blood volume from punches taken
within the circle (Mei et al. 2001).
State public health departments store resid-
ual newborn DBS for reanalysis if needed.
Residual specimens have been used for quality
control evaluation of new screening tests and
for forensic testing. More states are keeping
residual spots and making them available for
additional research purposes. Methods to
extract DNA from the DBS have been devel-
oped and have been used for genotyping in a
variety of studies (McCabe 1991; Paynter et al.
2006). With greater availability there is the
increasing potential to use these spots as a
resource for epidemiologic studies of pediatric
outcomes—for example, birth defects, child-
hood cancer, and autism. In addition, the spots
are of potential benefit for targeted mechanistic
and clinical studies. In epidemiologic studies of
rare pediatric diseases a case–control design is
often used in conjunction with an interview
with parents to obtain a parental and childhood
exposure history. With this self-reported infor-
mation, sometimes collected many years after
pregnancy, the potential for misclassification
can be significant for some exposures. In these
types of studies, there is a need for more precise
exposure assessment. Newborn blood spots
may offer a unique resource to assess certain
exposures at birth, with possible extrapolation
to earlier periods in pregnancy. The filter paper
matrix offers a way to preserve whole blood
whereby such diverse materials as amino and
organic acids, acylcarnitines, steroid and pep-
tide hormones, pesticides, metals, perchlorate,
human and infectious agent nucleic acids, anti-
bodies, other immune markers, and protein
adducts can be measured.
A multidisciplinary meeting was orga-
nized to examine the utility of dried blood
spots to measure environmental exposures.
Specific meeting questions included:
• What are the current technologies used to
quantify analytes?
• What are the current results?
• How reliable and valid are the findings?
• What are the next steps for evaluation?
• What are the future technologies?
Results and Issues
The meeting was held on 20 February 2007
at the University of North Carolina at Chapel
Hill. The audience consisted of epidemiolo-
gists, analytical and environmental chemists,
staff from state public health programs, the
Centers for Disease Control and Prevention
(CDC), and the National Institutes of
Health. Academics, state and federal govern-
ments, private industry, and medical institu-
tions were also represented.
Topics covered included an overview of
dried blood spot collection, storage and access,
and presentations on analytical methods to
measure flame-retarding chemicals and pesti-
cides, metals, perchlorate, infectious agents,
markers of immune status, protein adducts,
and the potential to assess maternal and pre-
natal environmental exposures. The list of
meeting organizers, presenters, and discussants
is available in Supplemental Material (online
at http://www.ehponline.org/members/2007/
10511/suppl.pdf). The presenters represented
selected laboratories currently performing
work on measuring specific agents. Several
analytical methods were presented, including
mass spectrometry, atomic absorption, molecu-
lar methods, and microfluidic techniques.
Presentations and discussions included issues
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ders. More states are keeping residual spots and making them available for research purposes. DNA
extraction from the DBS has been widely applied; however, the development of methods to meas-
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related to sample preparation, processing,
sensitivity, internal standards, and effects of
storage and other factors.
DBS collection, storage, and access. As
described by J. Mei (CDC), considerable vari-
ability exists among states regarding how DBS
are stored, the length of storage time, and in
policies for accessing specimens for research.
Approximately half of all states that responded
to a 2003 survey of U.S. health department
laboratory directors stored residual DBS for
6 months; > 40% of respondents stored spots
for > 12 months, thus indicating a potentially
large source of material available for research
(Olney et al. 2006). According to the survey,
15 states (31%) indicated they had a written
policy for how residual DBS could be used
outside of a newborn screening protocol,
whereas 10 of those 15 states (67%) said their
policy specified under what circumstances
residual DBS could be used with or without
personal identifiers. There is considerable
interest in accessing DBS material for research;
however, substantial costs are associated with
the storage, retrieval, and preparation of pro-
tocols. The lack of written policies addressing
laboratory, program, privacy, and consent
issues may limit the availability of specimens
(Olney et al. 2006). The ability to retrieve
specimens for environmental research will
require working relationships between
researchers and public health programs.
Measurement of environmental pollutants.
Measurement of several environmental pollu-
tants was discussed. Results were provided by
D.C. Patterson (CDC) for the application to
DBS samples of two-dimensional gas chro-
matography and isotope dilution, high resolu-
tion mass spectrometry for the measurement
of polybrominated biphenyl flame-retarding
chemicals and DDE (dichlorodiphenyl-
dichloroethylene), the metabolite of DDT
( d i c h l o r o d i p h e n y l t r i c h l o r o e t h a n e ) .
Preliminary studies have shown good recovery
of the pollutants from DBS at very low detec-
tion limits. The use of DBS to assess neonatal
perchlorate exposure was also discussed.
Environmental exposure to perchlorate has
been linked to changes in thyroid hormone
levels in U.S. women, leading to concerns
about potential perchlorate exposure and thy-
roid function in newborns. Newborn DBS
provide a convenient matrix for assessing both
thyroid function and perchlorate exposure.
Ion chromatography followed by electrospray
ionization tandem mass spectrometry was
used to quantify perchlorate in DBS with sta-
ble isotope dilution (18O4-perchlorate). As
shown by B. Blount (CDC), recovery of per-
chlorate from prepared DBS was very good
(within 11% of spike levels). Quantification
of perchlorate has several caveats: It is a non-
persistent compound, and serum levels may
vary in response to episodic exposures and
rapid clearance; filter paper variables such as
paper lot and manufacturer, spot volume,
hematocrit, and uneven distribution will have
to be defined; and traces of perchlorate have
been found in filter paper, requiring the sub-
traction of filter paper blanks from blood spot
perchlorate values.
Measurement of protein adducts. Data
were presented by S.M. Rappaport (University
of North Carolina, Chapel Hill) on the meas-
urement of protein adducts of carcinogens,
primarily 1,4-benzoquinone (1,4-BQ), in
hemoglobin (Hb) or human serum albumin
isolated from adult and infant DBS. Globin
(Gb) was selectively isolated from DBS fol-
lowed by a gas chromatography-mass spec-
trometry assay to detect the cysteinyl adducts
of 1,4-BQ in these proteins (1,4-BQ-Gb).
The pilot work demonstrated that it was feasi-
ble to isolate GB from DBS in high purity and
to detect adducts of at least one prominent
electrophile (1,4-BQ) in the Gb. Work is con-
tinuing to complete the assays on the remain-
ing DBS and to provide explanations for the
higher levels of 1,4-BQ-Gb observed in new-
born DBS compared to adult DBS.
Measurement of metals. Elements of inter-
est included major elements such as calcium
and magnesium; minor elements such as mer-
cury, iron, and zinc; and trace elements such as
lead, arsenic, cadmium, chromium, and cop-
per. E. Langer (University of Minnesota) iden-
tified that one of the main challenges to the
assessment of metals in DBS has been quanti-
fying the blood volume within a DBS punch.
Use of a ratio element such as magnesium or
calcium, which has a narrower range in cord
blood, is being explored to normalize other ele-
ment values. Thus far, some of the major ele-
ments in blood appear to produce fairly
consistent results across replicates, but the trace
elements have shown greater variability.
Assessment of immune status. New meth-
ods for the assessment of immune status using
microanalytical techniques with DBS were
discussed by T.M. Phillips (National Institutes
of Health). Recycling immunoaffinity array
and immunoaffinity capillary electrophoresis
have been adapted into a chip-based microflu-
idics system that allows for extremely small
sample volumes (< 100 nL) and rapid analysis
(~5 min), can provide considerable savings on
reagents, and has the potential for high
throughput (Phillips 2001). Using this tech-
nology, cytokine profiles were measured from
DBS to assess a) the immune response of new-
borns; b) the immune response in 6-month-
old infants after vaccination; and c) the
inflammation response of 1-month-old infants
after chlordane exposure.
Assessment of infectious agents. S. Dollard
(CDC) described the current applications of
DBS to measure infection, which are promoted
by international programs for HIV (human
immunodeficiency virus) and hepatitis C virus
(HCV) surveillance; these include anonymous
immunoglobulin (Ig)G testing for sentinel
surveillance for HIV and HCV in resource-
poor countries (Croom et al. 2006; Rollins
et al. 2007). A few states perform IgG anti-
body screening for maternal HIV infection,
and Massachusetts and New Hampshire are
routinely screening newborns for anti-
Toxoplasma IgM. Molecular methods can be
used for the direct detection of pathogen
DNA or RNA. The sensitivity of polymerase
chain reaction (PCR) testing can be limited by
the copy number of the pathogen in question.
For example, the number of typical genome
copies per 1/8-inch DBS punch (the typical
sample available for newborn screening)
would be as follows: 50–5,000 for hepatitis C
virus, 5–5,000 for HIV, and 0.1–50 for
cytomegalovirus. Therefore, more than the
standard 3-mm punch would be required for
reliable detection of many infectious agents
that have lower viral loads. Advances in tech-
nology will be necessary for the large-scale use
of DBS for detection of infectious agents. For
example, the only current automation for
making DBS punches deposits a 1/8-inch
punch into a 96-well plate, which is not suit-
able for most PCR testing.
Observations and
Recommendations
The meeting panel discussed a range of issues
surrounding the use of DBS in environmental
research and developed the following observa-
tions and recommendations:
• DBS remain a valuable resource for research,
and much progress has been made toward
expanding their application to clinical, epi-
demiologic, and environmental problems.
• Considerable variability exists among states in
how DBS are stored and the length of storage
time, and in policies for accessing specimens
for research. More should be done to develop
a comprehensive national system of newborn
blood spot collection, storage, and access to
address the fullest range of research questions.
• DBS provide analytical challenges to method
development and quantitation of analytes.
These include:
– Inadequate specimen volume: DBS have a
limited amount of serum/whole blood
available for testing. Methods need to
have sufficient sensitivity to accurately
measure small volumes. Many methods
for environmental toxicants require an
entire fully filled DBS for testing.
– Need for normalization of recovered sam-
ple: Because of variability in the whole
blood matrix, ratios or a reference mole-
cule that is proportional to blood volume
may be needed to normalize results.
– Need to define the stability and recoverabil-
ity of analytes for environmental toxicants
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and biomarkers: Storage time, temperature,
carryover, and number and location of spot
punches should be addressed.
– The stability, recoverability, and other
factors may vary for different analytes.
Published reports should provide suffi-
cient background information on these
parameters.
– Standardized shipping and storage proto-
cols are needed.
• To address these critical questions a priority
recommendation was made that a test set
including cord blood, maternal blood, and
blood spots be created. This set could be
used to simulate the effects of storage and
other factors and allow comparison and cali-
bration of findings.
• New technologic advances such as nano-
technology should be incorporated into the
evaluation of dried blood spots to improve
precision and reduce costs.
• Laboratory, environmental, and epidemiol-
ogy investigators should collaboratively
identify the priority toxicants to evaluate in
newborn blood spots.
• Future meetings should be conducted to
promote exchange of information and
collaboration.
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